Literature DB >> 4592011

Experimental murine leprosy. I. Clinical histological evidence for varying susceptibility of mice to infection with Mycobacterium lepraemurium.

O Closs, O A Haugen.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4592011

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


× No keyword cloud information.
  8 in total

1.  Relationship between delayed-type hypersensitivity and the progression of Mycobacterium lepraemurium infection.

Authors:  L W Poulter; M J Lefford
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

2.  Experimental murine leprosy: growth of Mycobacterium lepraemurium in C3H and C57/BL mice after footpad inoculation.

Authors:  O Closs
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

3.  Survival of Mycobacterium lepraemurium in C57BL mice after acquired protective immunity.

Authors:  M Løvik; O Closs
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

4.  Mycobacterium lepraemurium infection of nude athymic (nu/nu) mice.

Authors:  M J Lefford
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  Genetic control of resistance to Mycobacterium intracellulare infection in mice.

Authors:  Y Goto; R M Nakamura; H Takahashi; T Tokunaga
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

6.  Induction of cell-mediated immunity to Mycobacterium lepraemurium in susceptible mice.

Authors:  M J Lefford; P J Patel; L W Poulter; G B Mackaness
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Genetic studies of the murine corneal response to Pseudomonas aeruginosa.

Authors:  R S Berk; K Beisel; L D Hazlett
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

8.  Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG.

Authors:  A Forget; E Skamene; P Gros; A C Miailhe; R Turcotte
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.